Claim Construction Standards and SAS in Post-Grant Trials: Trends, Developments and What Lies Ahead

Andrew’s intellectual property practice focuses on contentious matters with an emphasis on patent office litigation. He has extensive experience in inter partes review proceedings involving a wide variety of technologies, where his representations have been on behalf of both petitioners and patent owners. In addition to patent office litigation, Andrew has extensive experience in District Court litigation and investigations at the International Trade Commission (ITC), including hearing experience at the ITC. He also assists clients with patent counseling matters, including patent prosecution and due diligence in support of business deals.

Andrew also has extensive experience representing foreign clients in contentious U.S. patent matters, with a specific emphasis on clients headquartered in Japan. Through this experience, he has developed a unique insight into business cultures outside the U.S. and an ability to guide such clients through the unique processes of patent litigation in the U.S.

Brendan is an associate in the Intellectual Property Group at White & Case and has more than 10 years of experience working in the field of patent law.  His practice focuses on a variety of intellectual property issues, including worldwide patent portfolio development, patent prosecution, due diligence, and litigation support.  Brendan has extensive experience providing freedom-to-operate, invalidity and patentability opinions, and he also assists the patent litigation group in contested proceedings, such as inter partes review and post grant review proceedings.  Brendan regularly works with clients and inventors from large corporations, start-up companies and universities to develop ideal intellectual property protection strategies of technologies such as enzyme replacement therapies, modified polypeptides, fusion proteins, small molecules, nucleic acid therapeutics (including CRISPR and RNAi), antibody development, methods of treatment, diagnostic methods, drug formulations, and dosage regimens.”